Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Background Episodes of depression are the most frequent cause of disability among patients with bipolar disorder. The effectiveness and safety of standard antidepressant agents for depressive episodes associated with bipolar disorder (bipolar depression) have not been well studied. Our study was designed to determine whether adjunctive antidepressant therapy reduces symptoms of bipolar depression without increasing the risk of mania. Methods In this double-blind, placebo-controlled study, we randomly assigned subjects with bipolar depression to receive up to 26 weeks of treatment with a mood stabilizer plus adjunctive antidepressant therapy or a mood stabilizer plus a matching placebo, under conditions generalizable to routine clinical care. A standardized clinical monitoring form adapted from the mood-disorder modules of the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, fourth edition, was used at all follow-up visits. The primary outcome was the percentage of subjects in each treatment group meeting the criterion for a durable recovery (8 consecutive weeks of euthymia). Secondary effectiveness outcomes and rates of treatment-emergent affective switch (a switch to mania or hypomania early in the course of treatment) were also examined. Results Forty-two of the 179 subjects (23.5%) receiving a mood stabilizer plus adjunctive antidepressant therapy had a durable recovery, as did 51 of the 187 subjects (27.3%) receiving a mood stab…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Based on negative placebo‐controlled data, we do not recommend paroxetine (level 2 negative).245”
In the citing paper
“Antimanic medications reduce depressive symptoms in only one-third of patients (2).”
From Adjunctive Bright Light Therapy for Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Trial (2018) · cites this paper as [2]
Citations
Cites
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
The mini international neuropsychiatric interview
Lecrubier, Y., Sheehan, D., Hergueta, T., & Weiller, E. (1998) · European Psychiatry · doi:10.1016/s0924-9338(99)80239-9 · Cited by 5,872
The Structured Clinical Interview for DSM-III-R (SCID): I: History, Rationale, and Description
Spitzer, R. L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820080032005 · Cited by 4,336
The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder
Judd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Maser, J., Solomon, D. A., Leon, A. C., Rice, J. A., & Keller, M. B. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.530 · Cited by 2,106
Prevalence and Treatment of Mental Disorders, 1990 to 2003
Kessler, R. C., Demler, O., Frank, R. G., Olfson, M., Pincus, H. A., Walters, E. E., Wang, P., Wells, K. B., & Zaslavsky, A. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa043266 · Cited by 1,910
Extending Indications for Long-Term Pharmacotherapy: Opportunities and Challenges
Kane, J. M. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.1 · Cited by 987
Tohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., Bowden, C., Mitchell, P. B., Centorrino, F., Risser, R., Baker, R. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.11.1079 · Cited by 908
Self-citationPerlis, R. H., Ostacher, M. J., Patel, J. K., Marangell, L. B., Zhang, H., Wisniewski, S. R., Ketter, T. A., Miklowitz, D. J., Otto, M. W., Gyulai, L., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.217 · Cited by 689
Self-citationPrevalence and Treatment of Mental Disorders
(2005) · New England Journal of Medicine · doi:10.1056/nejmc051936 · Cited by 650
Research works printed but not linked: 4
- Murray CJ, 1994, Bull World Health Organ, 72, 495
- Sheehan DV, 1998, J Clin Psychiatry, 59, 22
- Sachs GS, 1994, J Clin Psychiatry, 55, 391
- 10.1037/0021-843X.108.4.579 · doi:10.1037/0021-843x.108.4.579 · Paper page
Cited by
Items 701–800 of 935
Overview of Principles of Caring for Bipolar Patients
Akiskal, H. S., & Akiskal, K. K. (2011) · Wiley eBooks · doi:10.1002/9780470975114.ch25 · Cited by 1
“Overall, the foregoing considerations suggest that if and when patients accept treatment it is likely to be for the depressive phase, that is, with anti-depressants which, in monotherapy, have the distinct disadvantage to switch the patient into the excited phase – or at least not to protect against it (Sachs et al.,…”
BackgroundFamily Therapy Approaches to Bipolar Disorder
Miklowitz, D. J. (2010) · Wiley eBooks · doi:10.1002/9780470661277.ch34 · Cited by 1
Self-citationDSM‐V Perspectives on Classification of Bipolar Disorder
FAWCETT, J. A. (2010) · Wiley eBooks · doi:10.1002/9780470661277.ch5 · Cited by 1
Traitement d’un premier épisode dépressif dans le cadre du trouble bipolaire
Pringuey, D., Chérikh, F., Tible, O., & Giordana, B. (2010) · L Encéphale · doi:10.1016/s0013-7006(10)70007-5 · Cited by 1
CALM: A Mnemonic for Treatment Options for Bipolar Disorder
Sparhawk, R., & Ghaemi, S. N. (2008) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v10n0612f · Cited by 1
New Hope for Pharmacogenetic Testing
Nürnberger, J. I. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09040536 · Cited by 1
Altınbaş, K., Oral, T., Smith, D., & Craddock, N. (2010) · Dusunen Adam The Journal of Psychiatry and Neurological Sciences · doi:10.5350/dajpn2010230206 · Cited by 1
“reported that adjunctive antidepressant treatment for bipolar depression neither improved depressive symptoms nor increased the risk of switch to mania (10).”
BackgroundKeßler, U. (2014) · NORA - Norwegian Open Research Archives · Cited by 2
Tong, S. Y. C. (2012) · TSpace (University of Toronto) · Cited by 2
Evidence-based pharmacotherapy of bipolar disorder
Taylor, M. J., & Geddes, J. R. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511910395.004 · Cited by 1
Treatment-resistant mood disorders
Passos, I. C., & Quevedo, J. (2015) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/0101-60830000000054 · Cited by 1
Case Studies in Bipolar Depression: Best Practices for the Outpatient
Keck, P. E., McIntyre, R. S., & Shelton, R. C. (2007) · CNS Spectrums · doi:10.1017/s1092852900015893 · Cited by 1
Toniolo, R. A. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2016.tde-07122016-150647 · Cited by 2
Hammen, C. L., & Keenan‐Miller, D. (2012) · Wiley eBooks · doi:10.1002/9781118133880.hop208005 · Cited by 1
Pharmacological Treatment of Bipolar Depression
Young, A. H., & Nemeroff, C. B. (2010) · Wiley eBooks · doi:10.1002/9780470661277.ch23 · Cited by 1
Bocchetta, A. (2010) · Wiley eBooks · doi:10.1002/9780470749180.ch7 · Cited by 1
Easing the Burden of Bipolar Disorder: From Urgent Situations to Remission
(2008) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v10n0507 · Cited by 1
“COM observation that the role of adjunctive antidepressants is controversial in bipolar depression treatment.(12) The efficacy of augmentation with lamotrigine, inositol, or risperidone was examined in a STEP-BD study(39) of 66 patients with bipolar depression who were resistant to treatment with a mood stabilizer (li…”
BackgroundObsessive-Compulsive and Related Disorders
Jacoby, R. J., Baker, A. W., Jenike, M. A., Rauch, S. L., & Wilhelm, S. (2021) · Cambridge University Press eBooks · doi:10.1017/9780511846403.007 · Cited by 1
Reichenberg, L. W., & Seligman, L. (2016) · Wiley eBooks · doi:10.1002/9781394259465.ch4 · Cited by 1
Johnson, S. L., & Miklowitz, D. J. (2018) · Wiley eBooks · doi:10.1002/9781394258970.ch7 · Cited by 1
Self-citationTracing bipolar disorder to its developmental origin in the general population
Tijssen, M. J. A. (2008) · Research Publications (Maastricht University) · doi:10.26481/dis.20081023mt · Cited by 1
Gene expression and genetic association in bipolar disorder
Sears, C. (2012) · Otago University Research Archive (University of Otago) · Cited by 1
Kombinationen von Psychopharmaka
Messer, T., Tiltscher, C., & Schmauß, M. (2010) · Springer eBooks · doi:10.1007/978-3-211-85473-0_11 · Cited by 1
Lin, H. (2010) · Deep Blue (University of Michigan)
Estats mixtes, viratges i antidepressius: estudi d'una cohort de pacients bipolars
Ribas, M. V. (2012) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Innovation in the Treatment of Bipolar Depression
El‐Mallakh, R. S. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14com09351
İki Uçlu Bozukluk 1 ve İki Uçlu Bozukluk 2 Depresyon Tedavisi Arasindaki Farklar
Sayar, K. (2013) · Journal of Mood Disorders
Prise en charge médicamenteuse de la dépression bipolaire (recommandations internationales)
Jaffré, C., Vinckier, F., & Henry, C. (2023) · Elsevier eBooks · doi:10.1016/b978-2-294-77180-4.00046-9
Antidepressivos em depressões bipolares: risco versus eficácia
Valiengo, L. D. C. L., de Jesus, L. P., & Zanetti, M. V. (2009) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832009000600005
Novel Therapeutic Strategies for Bipolar Disorder
Machado‐Vieira, R., Manji, H. K., & Zarate, C. A. (2010) · Wiley eBooks · doi:10.1002/9780470661277.ch30 · Cited by 1
McGrath, P. J., & Roose, S. P. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139175869.004
Medikamente zur Behandlung bipolarer affektiver Störungen
Grunze, H., & Forsthoff, A. (2008) · Springer eBooks · doi:10.1007/978-3-540-68748-1_29
Dias, R. D. S. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2010.tde-28052010-101220 · Cited by 1
Non-pharmacological somatic treatments for bipolar depression
Sackeïm, H. A. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8567-5_11
Calkins, A. W., Hearon, B. A., & Otto, M. W. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511781919.004 · Cited by 1
Self-citation双極性障害の早期診断と治療(シンポジウム:うつ病の診断・治療上の問題点とコツ,2008年,第49回日本心身医学会総会(札幌))
輝明, 田., & 司, 小. (2009) · 心身医学 · doi:10.15064/jjpm.49.9_979
Casher, M. I., & Bess, J. D. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511933783.004
Ask the Experts: How are we currently dealing with bipolar disorder and what changes are occurring?
Mitchell, P. B. (2011) · Neuropsychiatry · doi:10.2217/npy.11.67
Vigilance Needed in Recognizing Behavior Changes in Patients Taking Statins
Goldstein, M. R., Mascitelli, L., & Pezzetta, F. (2008) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v10n0612b
Managing bipolar depression: a therapeutic challenge?
Feetam, C. (2011) · Progress in Neurology and Psychiatry · doi:10.1002/pnp.218
“An Progress in Neurology and Psychiatry 22 increased sta-biliser.”
BackgroundInfluentialAggressive Behavior After Ingestion of a High Dose of Sildenafil
Plesničar, B. K., & Plesničar, A. (2008) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v10n0612d
Etablir une base de recherche en psychiatrie
Shuchman, M., & Hébert, P. C. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.080583 · Cited by 1
Decisions about depression : treatment options depend on diagnosis : review
Moch, S. L. (2010) · Pharmacy management
In Bipolar Disorder Beyond 10 Weeks of Treatment, the TermAntidepressantsIs a Misnomer
Sparhawk, R. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11l06953
Comprehensive Pharmacologic Management of Bipolar Depression
McGirr, A., & Bond, D. J. (2014) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-014-0017-2
Drs. Rao, Hammen, and Poland Reply
Rao, U., Hammen, C. L., & Poland, R. E. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09030349r
Is Psychosocial Management Effective?
Saddichha, S., & Kumar, D. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.12.1451-b
The broad spectrum of bipolar disorder: implications for research and practice — a commentary
Young, A. H. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108092118
Recent Progress in the Pharmacotherapy of Bipolar Disorder
Mitchell, P. B., Loo, C. K. A., & Breakspear, M. J. (2009) · Future Neurology · doi:10.2217/fnl.09.18
Are antidepressants mood destabilizers?
Amerio, A., Odone, A., Marchesi, C., & Ghaemi, S. N. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.03.028
“With regard to acute efficacy, the largest RCT conducted on bipolar depression showed that the use of adjunctive antidepressant medication to mood stabilizers was ineffective and not superior to a mood stabilizer plus placebo (Sachs et al., 2007).”
Keßler, U., Schoeyen, H. K., Vaaler, A., Ødegaard, K. J., Bergsholm, P., Andreassen, O. A., Malt, U. F., & Morken, G. (2010) · European Psychiatry · doi:10.1016/s0924-9338(10)70268-6
Is Psychosocial Management Effective?—Reply
Miklowitz, D. J., Otto, M. W., Frank, E., Reilly-Harrington, N. A., Wisniewski, S. R., Kogan, J. N., Nierenberg, A. A., Calabrese, J. R., Marangell, L. B., Gyulai, L., et al. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.12.1452
Self-citationBenkert, O., Hautzinger, M., Graf-Morgenstern, M., Paulzen, M., & Himmerich, H. (2016) · Springer eBooks · doi:10.1007/978-3-662-49092-1_15
Bipolar disorder pharmacotherapy
Denko, T., & Thase, M. E. (2007) · Future Neurology · doi:10.2217/14796708.2.4.441
Self-citationTreatment Strategies for Bipolar Disorder: CALM SEA
Sparhawk, R., & Ghaemi, S. N. (2011) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.10l01106
On being bipolar without being bipolar
Goldberg, J. F. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108092123
Pharmacotherapy in mania and depression
Grunze, H. (2008) · Annals of General Psychiatry · doi:10.1186/1744-859x-7-s1-s65
“However, recent data of the STEP-BD program also question their true clinical effectiveness [ 3 ].”
ResultGoldberg, J. F. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09030331rr · Cited by 1
Dr. Schneck and Colleagues Reply
Schneck, C. D., Miklowitz, D. J., & Allen, M. H. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08030357r
Self-citationSchütz, C. G., & Sepehry, A. A. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09030349
RAPPORT, D. J., Paul, P., McGrady, A. V., Kaplish, D., McGinnis, R. A., & Whearty, K. (2013) · Academic Psychiatry · doi:10.1176/appi.ap.11120220
Self-citationMixed Depression and Rapid Cycling
Benazzi, F. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08030357
Psychotropic drug safety issues: continuing vigilance is needed
Alderman, C. P., Loutchkina, D., & Abarno, A. C. (2010) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.10.12
Atagün, M. İ., Altınbaş, K., Yeşilyurt, S., Yeşilbaş, D., Gülöksüz, S., & Oral, T. (2011) · Dusunen Adam The Journal of Psychiatry and Neurological Sciences · doi:10.5350/dajpn2012250208
“It was also suggested that using antidepressants in bipolar depression may lead to manic switches and rapid cycling and may become ineffective in treatment (2,3).”
BackgroundMethodProgress in Neurotherapeutics and Neuropsychopharmacology 2008
Cummings, J. L. (2008) · Progress in Neurotherapeutics and Neuropsychopharmacology · doi:10.1017/s1748232107000183
Treatment Resistant Bipolar Disorder
Özalp, E., & Karslıoğlu, E. H. (2015) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.5455/cap.20150209101507 · Cited by 1
ANTIDEPRESSANT ACTIVITY OF MOOD STABILIZERS
RYBAKOWSKI, J. K. (2012)
Reducing the Misdiagnosis of Bipolar Disorder Using Social Media
Smith, B. (2014)
Antidepressant medications and the longitudinal course of bipolar disorder revisited
Rasmussen, K. G. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.08.004
한국형 양극성 장애 약물치료 알고리듬 2014: 조증 삽화
우영섭, 박원명, 전덕인, 서정석, 이정구, 정종현, 김문두, 손인기, 심세훈, 민경준, et al. (2014) · 대한정신약물학회지
Potential novel treatments for bipolar depression
Zarate, C. A., & Manji, H. K. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8567-5_12 · Cited by 1
“For instance, a large-scale study funded by the National Institute of Mental Health (NIMH) failed to find any benefit to antidepressant use for patients with Bipolar I and II depression over the course of 26 weeks [ 1 ].”
BackgroundAre Add-On Antidepressants Ineffective for Bipolar Depression?
Roy‐Byrne, P. (2007) · Journal watch · doi:10.1056/jp200703280000001
Fowler, R. (2016) · British Journal of Hospital Medicine · doi:10.12968/hmed.2016.77.3.179
Depressive and Bipolar Disorders
Schwartz, E. R., Allespach, H. H., Sabbag, S. A., & Buford, U. (2016) · Springer eBooks · doi:10.1007/978-3-319-04414-9_33
“situation [22], and they may precipitate mania or hypomania if used as monotherapy.”
‘I am the man that mirthless lives’
Mason, D. P. (2016) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.115.173303
Add-On Antidepressants for Bipolar Depression?
Roy‐Byrne, P. (2007) · Journal watch · doi:10.1056/jw200704030000003
The dilemma in the concept and the management of bipolar disorder
Okasha, A. (2011) · Middle East Current Psychiatry · doi:10.1097/01.xme.0000405314.98496.3f
Family-Focused Therapy Study Raises New Questions
Bohr, N. (2014)
Module 12. Achieving concordance in the treatment of bipolar disorder
Gray, R. J., & Brown, E. (2012) · Nurse Prescribing · doi:10.12968/npre.2012.10.8.cpd1
This Issue: The Conundrum of Bipolar Depression
(2011) · Psychiatric Annals · doi:10.3928/00485713-20110627-01
We Need to Keep Learning from One Another
FAWCETT, J. A. (2010) · Psychiatric Annals · doi:10.3928/00485713-20100902-01
Agomelatin add-on bringt keine Vorteile
Engel, A. (2016) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-016-1760-2
Something Borrowed, Something Blue:Why is Bipolar Disorder an Orphan?
Nierenberg, A. A. (2010) · CNS Spectrums · doi:10.1017/s1092852900000250
Self-citationPharmacologic and somatic treatments for bipolar depression
Giner, L., Kelly, S. A., & Oquendo, M. A. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139175869.007
Clinical Management of Bipolar Disorder
Mitchell, P. B. (2013) · doi:10.2217/9781780842585
Medications Used in Bipolar Depression, Mixed States, and Rapid Cycling
(2013) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814343664_0014
Effectiveness Trials in Bipolar Disorders
Nierenberg, A. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-405170-6.00003-8
Self-citationLaux, G., & Bauer, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_56
(2015) · The American Pharmacists Association eBooks · doi:10.21019/9781582122175.ch29
Bupropion Maintenance Treatment in Refractory Bipolar Depression: A Case Report
Dehning, J., Grunze, H., & Hausmann, A. (2017) · Clinical Practice and Epidemiology in Mental Health · doi:10.2174/1745017901713010043
“DISCUSSION AND CONCLUSION Different from North America, bupropion still appears underused in other countries as a treatment of choice in bipolar depression, and with the only large randomized, placebo-controlled acute study as add-on to mood stabilizer having failed [20], it often receives a low grade of recommendatio…”
BackgroundWelton, R. S., & Roman, B. J. B. (2017) · Wiley eBooks · doi:10.1002/9781119152606.ch4
Hättenschwiler, J., Höck, P., Hatzinger, M., Seifritz, E., & Modestin, J. (2009) · Swiss Medical Forum ‒ Schweizerisches Medizin-Forum · doi:10.4414/smf.2009.06969
Troubles bipolaires: traitement
Hättenschwiler, J., Höck, P., Hatzinger, M., Seifritz, E., & Modestin, J. (2009) · Forum Médical Suisse ‒ Swiss Medical Forum · doi:10.4414/fms.2009.06969
Rethinking the Approach for the Treatment of Bipolar Depression
RAPPORT, D. J., Thummalapally, R., & Delaney, J. (2018) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20170032
Self-citationValle, L. P. (2017) · Louisiana State University · doi:10.31390/gradschool_theses.4565
Myczkowski, M. L. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2018.tde-02082018-100807
A 30-Year-Old Woman Who Has Difficulty Getting Out of Bed
Berry, R. B., & Wagner, M. H. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-7051-9.00125-x
Júnior, B. D. S. P. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2018.tde-02082018-102334
Machine Learning for Data-driven Biomedical Decision Making
Luckett, D. J. (2018) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/v40f-rm50
Metadata
- Authors
- Sachs, G. S., Nierenberg, A. A., Calabrese, J. R., Marangell, L. B., Wisniewski, S. R., Gyulai, L., Friedman, E. S., Bowden, C. L., Fossey, M. D., Ostacher, M. J., Ketter, T. A., Patel, J., Hauser, P., Rapport, D., Martinez, J. M., Allen, M. H., Miklowitz, D. J., Otto, M. W., Dennehy, E. B., & Thase, M. E.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- University Hospitals Cleveland Medical Center (US)
- Baylor College of Medicine (US)
- University of Pittsburgh (US)
- University of Pennsylvania (US)
- The University of Texas at San Antonio Health Science Center (US)
- University of Oklahoma (US)
- Stanford Medicine (US)
- University of Massachusetts Chan Medical School (US)
- University of Toledo (US)
- University of Colorado Boulder (US)
- Boston University (US)
- Purdue University West Lafayette (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-04-26
- Volume
- 356
- Issue
- 17
- Pages
- 1711-1722
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2166423384
- Semantic Scholar
- c224a40d0ffd6471e7b72b38060d169ba1cdec34
- Cited by
- 937
- References
- 27
- Citations by year
- 2026: 16 · 2025: 16 · 2024: 33 · 2023: 17 · 2022: 15 · 2021: 68 · 2020: 33 · 2019: 29 · 2018: 36 · 2017: 28 · 2016: 53 · 2015: 47 · 2014: 51 · 2013: 52 · 2012: 61
- FWCI
- 56.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01mh80001-12-0-0)
- National Institute of Mental Health (N01-MH80001)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- bipolar depression, adjunctive antidepressant therapy, mood stabilizers, euthymia, bipolar disorder, antidepressant safety
- MeSH terms
- Adult, Bipolar Disorder, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Bupropion, Treatment Outcome, Paroxetine, Antidepressive Agents, Second-Generation, Antimanic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.